Troutman Pepper Hamilton Sanders advised Apnimed on the deal.Apnimed, a clinical-stage pharmaceutical company focused on developing oral pharmacologic treatments to address obstructive sleep apnea (OSA) and…
Apnimed’s Extended Series C Financing Round
